Danaher

Extracted Attributes

Danaher Corporation

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Web Search Results

• Danaher Corp Company Profile

  Danaher Corp (Danaher) is a science and technology company that conducts business in biotechnology, life sciences, and diagnostics. The company provides a wide range of testing instruments, medical diagnostic solutions, life science research tools, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting, and characterization businesses. Danaher offers its products and services to pharmaceutical and biotechnology companies, healthcare providers, and research institutions through independent distributors in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. It has manufacturing facilities in Europe, Australia, Asia, and the Americas. Danaher is headquartered in [...] Asia, and the Americas. Danaher is headquartered in Washington, DC, the US.

• Danaher

  Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers around the world to accelerate breakthroughs from idea to impact, moving with the speed and certainty they need to advance life‑changing science. By working side‑by‑side with researchers, scientists, and clinicians, we solve their hardest problems—together, bringing the right expertise, technologies, and partners from across our portfolio to architect the most effective solutions. Through our connected ecosystem of companies operating at global scale, we help customers streamline and integrate their workflows across Life Sciences, Diagnostics, Biotechnology, and beyond—empowering them to achieve results [...] greater confidence, IDT is accelerating the journey from promising science to potential therapies, helping innovators move forward with greater certainty. [Likes: 75, Comments: 2]; Danaher (1w): Communities face complex challenges every day. Solving them takes people willing to contribute their time, expertise, and passion. Through Danaher's Donations for Doers program, associates support organizations tackling challenges in communities around the world. In this four-part series, we're sharing a few of those stories. For Pauline Adejo , Senior Scientist at Pall Corporation , that means helping address food insecurity through her volunteer work with Long Island Cares. Having witnessed the realities of food insecurity firsthand, she now organizes food drives that help connect local families [...] ## Media - Images: - Logo: Company Logo ## Additional Additional jobs info: Danaher (4,179 open jobs). Analyst (694,057 open jobs). Director (1,220,357 open jobs). Manager (1,880,925 open jobs). Engineer (555,845 open jobs). Vice President (235,270 open jobs). Project Manager (253,048 open jobs). Associate (1,091,945 open jobs). Scientist (48,969 open jobs). Specialist (768,666 open jobs). Human Resources Specialist (34,340 open jobs). Human Resources Director (16,428 open jobs). Human Resources Business Partner (19,788 open jobs). Account Manager (121,519 open jobs). Intern (71,196 open jobs). Human Resources Manager (31,339 open jobs). Senior Director (117,535 open jobs). Head (1,018,536 open jobs). Marketing Manager (106,879 open jobs). President (92,709 open jobs)

• Danaher Corporation

  Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea [...] | Headquarters in Washington, D.C. | | Type | Public | | Traded as | NYSE: DHR S&P 100 component S&P 500 component | | Industry | Healthcare industry | | Founded | 1969; 57 years ago (1969) (as DMG) 1984; 42 years ago (1984) (as Danaher) | | Founders | Steven Rales Mitchell Rales | | Headquarters | Washington, D.C., US | | Area served | Worldwide | | Key people | Steven Rales (chairman of the board) Mitchell Rales (chairman of the executive committee) Rainer Blair (president "President (corporate title)") and CEO) | | Revenue | Increase US$24.6 billion (2025) | | Net income | Decrease US$3.61 billion (2025) | | Number of employees | c. 63,000 (2024) | | Divisions "Division (business)") | List of divisions | | Website | www.danaher.com Edit this at Wikidata | | Footnotes | [...] In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and

• Danaher

  Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We help improve and save lives by enabling faster, more accurate diagnoses and helping customers reduce the time and cost needed to discover, develop and deliver life-changing therapies. Our culture of continuous improvement—powered by the Danaher Business System—means we never stop finding better ways to move ideas into real-world impact. When time saves lives, speed with certainty matters. At Danaher we unite diagnostics, life sciences, and biotech to deliver faster, smarter solutions—because lives depend on it. The impact of our industry-leading businesses - Abcam, Aldevron, Beckman Coulter Diagnostics, Beckman Coulter Life

• About Danaher | Our Culture & Core Values

  Woman making point in meeting Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. What differentiates Danaher is not only what we do, but how we do it—accelerating the journey from idea to impact through a connected ecosystem of companies, deep scientific expertise, and a culture of continuous improvement powered by the Danaher Business System. Working as one Danaher, our businesses bring the right combination of technologies, scale and partnership to solve the hardest problems—and help customers move from discovery to delivery faster.

• Instance Of

  Q101352